Jun 26, 2020 by Brian Orelli, PhDFDA Rejects AbbVie's Macular Degeneration Drug Abicipar PegolThe drug, which AbbVie gained in its acquisition of Allergan, was supposed to be a growth driver for the company.
Jun 25, 2020 by Brian Orelli, PhDIs Moderna Stock a Hold?Holding at this point requires the biotech's COVID-19 vaccine to be successful without major competition.
Jun 22, 2020 by Brian Orelli, PhDGuardant Health's Blood Cancer Test Detects Early-Stage Colon CancerResults from a small study will need to be validated by an ongoing study of 10,000 patients.
Jun 22, 2020 by Brian Orelli, PhDHere's Why NantKwest Rocketed Higher TodayInvestors are excited about the biotech's COVID-19 vaccine targeting a different part of the novel coronavirus.
Jun 18, 2020 by Brian Orelli, PhDRoche's Rheumatoid Arthritis Drug Actemra Fails to Help COVID-19 Patients With PneumoniaThere are still two ongoing studies of the drug in patients infected with the novel coronavirus.
Jun 18, 2020 by Brian Orelli, PhDPfizer and Sangamo's Gene Therapy Continues to Help Patients with Hemophilia in Clinical TrialWhile the data looks good so far, the duo's treatment is behind a similar BioMarin therapy in the testing and approval process.
Jun 17, 2020 by Brian Orelli, PhDIs Dexamethasone the Best Treatment for COVID-19?A cheap, generically available steroid appears to reduce mortality in patients with the harshest coronavirus cases.
Jun 15, 2020 by Brian Orelli, PhDHere's Why Momenta Jumped Higher TodayPositive phase 2 clinical trial data puts the biotech's lead drug candidate on a good path forward.
Jun 14, 2020 by Brian Orelli, PhDWho Can Donate Plasma for COVID-19 Patients?Antibodies of recovered patients can help treat people who are infected with the novel coronavirus.
Jun 12, 2020 by Brian Orelli, PhDMylan and Biocon Gain FDA Approval for Insulin Equivalent to Sanofi's LantusCheaper insulin is on its way.
Jun 10, 2020 by Brian Orelli, PhDAbbVie's Humira on Steroids (Literally) Treats Rheumatoid Arthritis Better Than the OriginalThat's the finding of a clinical trial of ABBV-3373, a new type of antibody-drug conjugate.
Jun 9, 2020 by Brian Orelli, PhDHere's Why Fate Therapeutics Stock Jumped Higher TodayThe company has some additional capital to support the development of its pipeline.
Jun 8, 2020 by Brian Orelli, PhDHere's Why BioCryst Pharmaceuticals Jumped 15% in MayInvestors are excited about the biotech's potential.
Jun 8, 2020 by Brian Orelli, PhDHere's Why Vir Biotechnology Jumped 12% in MayPreclinical data for its COVID-19 treatment looked promising.
Jun 5, 2020 by Brian Orelli, PhDFDA Evaluates 5 More COVID-19 Antibody TestsIndependent analysis shows some of the post-exposure tests work fairly well.
Jun 4, 2020 by Brian Orelli, PhDInovio to Start a Phase 1/2 Study of its COVID-19 Vaccine in South KoreaThe study is scheduled to start this month.
Jun 4, 2020 by Brian Orelli, PhDHere's Why Moderna Only Released Limited Phase 1 Data for Its Novel Coronavirus VaccineThe decision came as the result of a natural disagreement between the scientists and the investors.
Jun 3, 2020 by Brian Orelli, PhDPliant Therapeutics Up 33% on IPO PricingInvestors are excited about the biotech's prospects, but the company still has a long road ahead.
Jun 2, 2020 by Brian Orelli, PhDHere's Why Arena Pharmaceuticals Jumped Higher TodayA rival's drug validates the biotech's approach.
Jun 1, 2020 by Brian Orelli, PhDHere's Why Evolent Health Shares Crashed TodayThe healthcare administration company may lose a major partner.
